Lupus Education Alliance Program
NCT05243875 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 274
Last updated 2025-08-03
Summary
Randomized controlled trial of a COVID-19 behavioral and educational intervention for people with systemic lupus erythematosus (SLE).
Conditions
Interventions
- BEHAVIORAL
-
LEAP Education + Navigation
COVID education involving providing information about COVID for people with SLE and CDC recommendations for testing, testing options (e.g., pharmacies, doctors' offices, at-home), treatment in the event of a positive COVID result, and current recommendations around vaccination for those with SLE; and (2) navigation, which involves individual tailoring of information about where and how to get tested, and where to get vaccinated, and when appropriate, guiding participants in scheduling testing and vaccination appointments.
- BEHAVIORAL
-
LEAP Education
COVID education involving providing information about COVID for people with SLE and CDC recommendations for testing, testing options (e.g., pharmacies, doctors' offices, at-home), treatment in the event of a positive COVID result, and current recommendations around vaccination for those with SLE.
Sponsors & Collaborators
-
University of Alabama at Birmingham
collaborator OTHER -
Ochsner Health System
collaborator OTHER -
Louisiana State University Health Sciences Center in New Orleans
collaborator OTHER -
Tulane University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-11-01
- Primary Completion
- 2025-06-15
- Completion
- 2025-06-15
Countries
- United States
Study Locations
More Related Trials
-
Lupus Intervention for Fatigue Trial
NCT02653287 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Women Empowered to Live With Lupus Study
NCT02988661 ·Status: COMPLETED ·Phase: NA
-
Individualized Patient Decision Making for Treatment Choices Among Minorities With Lupus
NCT02319525 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of a Knowledge-based Intervention for Patients With Cutaneous Lupus Erythematosus
NCT01629784 ·Status: COMPLETED ·Phase: NA
-
Aerobic Exercise in Women With Systemic Lupus Erythematosus
NCT03186794 ·Status: TERMINATED ·Phase: NA
-
Utilizing Qualitative and Quantitative Methods to Understand a New Model of Type 1 and 2 Systemic Lupus Erythematosus (SLE)
NCT05426902 ·Status: COMPLETED ·Phase: NA
-
CCCR Lupus Patient Navigator Program
NCT04461158 ·Status: COMPLETED ·Phase: NA
-
FLARE Lupus Research Study Systemic Lupus Erythematosus
NCT03426384 ·Status: COMPLETED ·Phase: NA
-
Whole Health Empowerment for Endotypes of Lupus: Improving Quality of Life in SLE
NCT06720584 ·Status: COMPLETED ·Phase: NA
-
Research Accelerated by You Lupus Registry
NCT06927219 ·Status: RECRUITING
-
Prevention of Atherosclerosis and Heart Disease in Patients With Systemic Lupus Erythematosis (SLE)
NCT00054938 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Telehealth Initiative on Lupus Patients
NCT05329831 ·Status: COMPLETED ·Phase: NA
-
Mediterranean vs. High-Fermented-Food Diet Adherence on Inflammation in Lupus
NCT05379725 ·Status: TERMINATED ·Phase: NA
-
Fatigue in Lupus Intervention Programmes (FLIP)
NCT06308770 ·Status: RECRUITING ·Phase: NA
-
Validation of Patient E-tool to Measure Systemic Lupus Activity
NCT05763225 ·Status: COMPLETED
-
Study of Individualized Instruction Versus Pamphlet in Systemic Lupus Erythematosus
NCT00004756 ·Status: COMPLETED ·Phase: NA
-
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
NCT01405196 ·Status: COMPLETED ·Phase: PHASE2
-
Intervention to Improve Communication and Medication Adherence in Lupus
NCT06458075 ·Status: RECRUITING ·Phase: NA
-
Immune Response to SARS-CoV-2 Vaccination in Systemic Lupus
NCT04894253 ·Status: TERMINATED
-
Weaning of Immunosuppression in Nephritis of Lupus
NCT01284725 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Tolerance of Abacavir/Lamivudine Treatment in Patients With Systemic Lupus Erythematosus
NCT06356740 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Prospective Evaluation of Decision and Compliance With Antimalarials in Patients With Systemic Lupus
NCT02364908 ·Status: COMPLETED ·Phase: NA
-
Reducing Disparities in Medication Adherence in SLE
NCT03738826 ·Status: COMPLETED ·Phase: NA
-
Psycho-social Consequences of Systemic Lupus Erythematosus
NCT03913754 ·Status: COMPLETED
-
The HOP-STEP Intervention: Improving Maternal Health in Women With Lupus sIRB
NCT05818254 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA